Additional somatic mutations (e.g., TET2, SRSF2, ASXL1, EZH2, CBL, RUNX1, and RAS) have been found in 90% of AdvSM patients, especially in SM-AHN [50,51,52]. Here, SRSF2 is linked to systemic mastocytosis.